Skip to content
Menu

Eli Lilly and Company LLY

Full chart Compare
Set alert

Price alert · LLY

All alert types
1,443.50 USD +17.95 (+1.26%)

Regular-session close

1,439.99 -3.51 -0.24%

After hours · Nov 13, 7:57 PM ET

1,419.81 Day range 1,449.64
851.21 52-week range 1,443.50
YTD
+34.32%
1 year
+41.12%

Discussion (582)

Sign in to join the discussion

Member LLY 6 months ago #41

$LLY

Wait till RETA hits -3 X Agonist
In the Peptide world that's ALL people want. Game Changer. Zero food noise -no nausea. It will wipe out all others

Lilly's triple agonist, retatrutide, delivered weight loss of up to an average of 71.2 lbs along with substantial relief from osteoarthritis pain in first successful Phase 3 trial- 2025

StockMaster LLY 6 months ago #42

$LLY...AS I've said many times before...you don't sell this gem...it's simply utterly foolish to reduce LLY to just GLP-1...it has the best pipeline of all pharmaceutical stocks.

Tim F LLY 6 months ago #43

Just their pipeline all carries a high premium. Healthcare stocks are being sold off and cash is going into semi’s and AI. It’s so outta favor now

StockMaster LLY 6 months ago #45

$LLY...NOW, after a 23% correction, it's really starting to get ridiculous... what's the problem? Sales and results are excellent, as is the pipeline.
Earnings will be solid
Greetings from Germany